Clinical Trial Update: Evaluation of a Plasma Marker (p-Tau217) for the Biological Diagnosis of Alzheimer's Disease, and Comparison With CSF Markers [NA]

View source ↗

Summary

A clinical trial evaluating the plasma biomarker p-tau217 for biological diagnosis of Alzheimer's disease and comparing it with CSF markers; recruitment is ongo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Centre Hospitalier Universitaire, Amiens | Conditions: Alzheimer's Disease, Biomarkers | NA | Status: RECRUITING